Alignment Healthcare Inc
For the period ended Dec 31, 2023. Filed Feb 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 27, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Alignment Healthcare, Inc. | ||
| Date: February 27, 2024 | By: | /s/ John Kao |
|---|---|---|
| John Kao | ||
| President and Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ John Kao | President and Chief Executive Officer (Principal Executive Officer) | February 27, 2024 |
| John Kao | ||
| /s/ Thomas Freeman | Chief Financial Officer (Principal Financial Officer) | February 27, 2024 |
| Thomas Freeman | ||
| /s/ Joseph Konowiecki | Chairman of the Board | February 27, 2024 |
| Joseph Konowiecki | ||
| /s/ Jody Bilney | Director | February 27, 2024 |
| Jody Bilney | ||
| /s/ Thomas Carella | Director | February 27, 2024 |
| Thomas Carella | ||
| /s/ David Hodgson | Director | February 27, 2024 |
| David Hodgson | ||
| /s/ Yon Jorden | Director | February 27, 2024 |
| Yon Jorden | ||
| /s/ Jacqueline Kosecoff | Director | February 27, 2024 |
| Jacqueline Kosecoff | ||
| /s/ Jeffrey Margolis | Director | February 27, 2024 |
| Jeffrey Margolis | ||
| /s/ Margaret McCarthy | Director | February 27, 2024 |
| Margaret McCarthy | ||
| /s/ Mark McClellan | Director | February 27, 2024 |
| Mark McClellan | ||
| /s/ Robbert Vorhoff | Director | February 27, 2024 |
| Robbert Vorhoff | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.